139 related articles for article (PubMed ID: 18368480)
1. Design and efficient synthesis of novel GM2 analogues with respect to the elucidation of the function of GM2 activator.
Komori T; Ando T; Imamura A; Li YT; Ishida H; Kiso M
Glycoconj J; 2008 Oct; 25(7):647-61. PubMed ID: 18368480
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation.
Li YT; Li SC; Hasegawa A; Ishida H; Kiso M; Bernardi A; Brocca P; Raimondi L; Sonnino S
J Biol Chem; 1999 Apr; 274(15):10014-8. PubMed ID: 10187778
[TBL] [Abstract][Full Text] [Related]
3. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.
Li YT; Li SC; Kiso M; Ishida H; Mauri L; Raimondi L; Bernardi A; Sonnino S
Biochim Biophys Acta; 2008 Mar; 1780(3):353-61. PubMed ID: 17967427
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and enzymatic susceptibility of a series of novel GM2 analogs.
Fuse T; Ando H; Imamura A; Sawada N; Ishida H; Kiso M; Ando T; Li SC; Li YT
Glycoconj J; 2006 Jul; 23(5-6):329-43. PubMed ID: 16897176
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of a modified ganglioside, de-N-acetyl GM2.
Fujita S; Numata M; Sugimoto M; Tomita K; Ogawa T
Carbohydr Res; 1994 Oct; 263(2):181-96. PubMed ID: 7805050
[TBL] [Abstract][Full Text] [Related]
6. Interaction of GM2 activator protein with glycosphingolipids.
Hama Y; Li YT; Li SC
J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the enzymatic resistance of the GM2 ganglioside.
Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
[No Abstract] [Full Text] [Related]
8. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM2: a potential biomarker for cholangiocarcinoma.
Talabnin K; Talabnin C; Kumagai T; Sutatum N; Khiaowichit J; Dechsukhum C; Ishihara M; Azadi P; Sripa B
J Int Med Res; 2020 Jul; 48(7):300060520903216. PubMed ID: 32692591
[TBL] [Abstract][Full Text] [Related]
10. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
11. Preparation and enzymatic degradation of monosulfogangliotriaosylceramide.
Ishizuka I; Nagai K; Kawaguchi K; Tadano-Aritomi K; Toida T; Hirabayashi Y; Li YT; Li SC
J Biol Chem; 1985 Sep; 260(20):11256-61. PubMed ID: 3928630
[TBL] [Abstract][Full Text] [Related]
12. Facile method for the preparation of lyso-GM1 and lyso-GM2.
Ando T; Li SC; Ito M; Li YT
J Chromatogr A; 2005 Jun; 1078(1-2):193-5. PubMed ID: 16010718
[TBL] [Abstract][Full Text] [Related]
13. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
14. Localization of UDP-GalNAc:NeuAc alpha 2,3Gal-R beta 1,4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human stomach. Enzymatic synthesis of a fundic gland-specific ganglioside and GM2.
Dohi T; Hanai N; Yamaguchi K; Oshima M
J Biol Chem; 1991 Dec; 266(35):24038-43. PubMed ID: 1748676
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides.
Li SC; Nakamura T; Ogamo A; Li YT
J Biol Chem; 1979 Nov; 254(21):10592-5. PubMed ID: 115863
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
17. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa.
Dohi T; Ohta S; Hanai N; Yamaguchi K; Oshima M
J Biol Chem; 1990 May; 265(14):7880-5. PubMed ID: 2139874
[TBL] [Abstract][Full Text] [Related]
18. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
Yadao F; Hechtman P; Kaplan F
Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
[TBL] [Abstract][Full Text] [Related]
19. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
Antoine T; Priem B; Heyraud A; Greffe L; Gilbert M; Wakarchuk WW; Lam JS; Samain E
Chembiochem; 2003 May; 4(5):406-12. PubMed ID: 12740812
[TBL] [Abstract][Full Text] [Related]
20. Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications.
Jacques S; Rich JR; Ling CC; Bundle DR
Org Biomol Chem; 2006 Jan; 4(1):142-54. PubMed ID: 16358009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
